Effect of insulin-mimetic vanadyl sulfate on cytochrome P450 2E1-dependent p-nitrophenol hydroxylation in the liver microsomes of streptozotocin-induced type 1 diabetic rats.
CYP2E1 is known to be induced in streptozotocin (STZ)-treated diabetic rats (STZ rats), and its induction is improved by insulin. We have examined the age-dependent changes of CYP2E1 in the liver microsomes of type 1 diabetic STZ rats, the effects of VOSO4 on the contents of total P450 and CYP2E1, and the activities of CYP2E1 in terms of p-nitrophenol hydroxylation. The contents of P450 and CYP2E1 and CYP2E1 activity were enhanced with the development of diabetes. When the hyperglycemia of STZ rats was improved by daily intraperitoneal injections of VOSO4 for 10 days at the doses of 7 mg/kg body weight for 5 days, 5 mg/kg for the following 3 days, and then 2.5 mg/kg for 2 days, the P450 and CYP2E1 levels and CYP2E1 activity were lowered than those in the untreated STZ rats. To understand the mechanism underlying CYP2E1-dependent hydroxylation activity, the production of reactive oxygen species was examined in the NADPH-liver microsomal systems by ESR spin-trapping. Singlet oxygen (1O2) was detected in all microsomal systems, while superoxide anion radical(*O2-) and hydroxyl radical (*OH) were not. On the basis of these results, we conclude that (1) CYP2E1 level and activity are enhanced in the diabetic state, however, they are improved by VOSO4 treatment, and (2) 1O2 is generated during CYP2E1-dependent substrate oxygenation.
Kataoka
Sayuri
S
Department of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8414, Japan.
Yasui
Hiroyuki
H
Hiromura
Makoto
M
Sakurai
Hiromu
H
D000367:Age Factors; D000704:Analysis of Variance; D000818:Animals; D019392:Cytochrome P-450 CYP2E1 / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004578:Electron Spin Resonance Spectroscopy; D006900:Hydroxylation; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D015151:Immunoblotting; D008862:Microsomes, Liver / Q000187:drug effects*; D009596:Nitrophenols / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D019097:Spin Trapping; D013311:Streptozocin; D017968:Vanadium Compounds / Q000494:pharmacology*
D007004:Hypoglycemic Agents; D009596:Nitrophenols; D017968:Vanadium Compounds; D013311:Streptozocin; C034028:vanadyl sulfate; D019392:Cytochrome P-450 CYP2E1; C024836:4-nitrophenol